RIZATRIPTAN N-OXIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide)

In Stock
Ready to ship

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C15H19N5O

Product Type

Pharmaceutical Analytical Impurities

$750.00

Quantity

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Current Lot Information

Current Lot:

F246U0

Harmonized System (HS) Code *:

29339910

UN No:

N/A

NDC No:

N/A

Molecular Formula

C15H19N5O

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No

USP Certificates/Product Information Sheets and Valid Use Dates

Valid Use Date

Country of Origin*

Material Origin*

F246U0

1A10040-F246U0

See Product Information Sheet

India

Chemical Synthesis

Lot No

F246U0

USP Certificates/Product Information Sheets and Valid Use Dates

1A10040-F246U0

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

Chemical Synthesis

Frequently bought together

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C15H19N5O

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A06380

CAS No.

252964-68-4

Molecular Formula

C23H29N5O2

Product Type

Pharmaceutical Analytical Impurities

Catalogue No.

1A10130

CAS No.

91189-59-2

Molecular Formula

C17H17Cl2NO4

Product Type

Pharmaceutical Analytical Impurities